These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33525304)

  • 21. Clinical features of primary hyperthyroidism caused by Graves' disease admixed with resistance to thyroid hormone (P453T).
    Sato H
    Endocr J; 2010; 57(8):687-92. PubMed ID: 20574139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Graves' hyperthyroidism following primary hypothyroidism due to Hashimoto's thyroiditis in a case of thyroid hemiagenesis: case report.
    Ruchała M; Szczepanek E; Skiba A; Czepczyński R; Sowiński J
    Neuro Endocrinol Lett; 2008 Feb; 29(1):55-8. PubMed ID: 18283259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of Hashimoto's encephalopathy associated with Graves' disease].
    Saito H; Fujita N; Miyakoshi M; Arai A; Nagai H
    Rinsho Shinkeigaku; 2002 Jul; 42(7):619-22. PubMed ID: 12661107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of 25 (OH) Vitamin D deficiency on Hashimoto's Thyroiditis.
    Bakr HG; Meawed TE
    Egypt J Immunol; 2017 Jun; 24(2):53-62. PubMed ID: 29528579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Childhood Graves' ophthalmopathy: results of a European questionnaire study.
    Krassas GE; Segni M; Wiersinga WM
    Eur J Endocrinol; 2005 Oct; 153(4):515-21. PubMed ID: 16189172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.
    Okamoto Y; Hamada N; Saito H; Ohno M; Noh J; Ito K; Morii H
    J Clin Endocrinol Metab; 1989 Apr; 68(4):730-4. PubMed ID: 2921308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient Graves' hyperthyroidism during pregnancy in a patient with Hashimoto's hypothyroidism.
    Lu R; Burman KD; Jonklaas J
    Thyroid; 2005 Jul; 15(7):725-9. PubMed ID: 16053390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
    McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
    Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of thyroid-associated ophthalmopathy: an autoimmune disorder of the eye muscle associated with Graves' hyperthyroidism and Hashimoto's thyroiditis.
    Wall JR; Bernard N; Boucher A; Salvi M; Zhang ZG; Kennerdell J; Tyutyunikov A; Genovese C
    Clin Immunol Immunopathol; 1993 Jul; 68(1):1-8. PubMed ID: 8513588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of antithyroid drugs on the occurrence of antibodies against type 2 deiodinase (DIO2), which are involved in hyperthyroid Graves' disease influencing the therapeutic efficacy.
    Molnár I; Szentmiklósi JA; Gesztelyi R; Somogyiné-Vári É
    Clin Exp Med; 2019 May; 19(2):245-254. PubMed ID: 30610492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial.
    Watt T; Cramon P; Bjorner JB; Bonnema SJ; Feldt-Rasmussen U; Gluud C; Gram J; Hansen JL; Hegedüs L; Knudsen N; Bach-Mortensen P; Nolsøe R; Nygaard B; Pociot F; Skoog M; Winkel P; Rasmussen AK
    Trials; 2013 Apr; 14():119. PubMed ID: 23782950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases.
    Takasu N; Yamada T; Sato A; Nakagawa M; Komiya I; Nagasawa Y; Asawa T
    Clin Endocrinol (Oxf); 1990 Dec; 33(6):687-98. PubMed ID: 1982861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
    Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
    Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
    Schumm-Draeger PM
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
    Maugendre D; Massart C
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graves' disease and Turner's syndrome.
    Marcocci C; Bartalena L; Martino E; Fenzi GF; Pinchera A
    J Endocrinol Invest; 1980; 3(4):429-31. PubMed ID: 6894158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-cardiolipin antibodies in autoimmune thyroid diseases.
    Paggi A; Caccavo D; Ferri GM; Di Prima MA; Amoroso A; Vaccaro F; Bonomo L; Afeltra A
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):329-33. PubMed ID: 8187296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.